TherapeuticsMD, Inc. — Director's Dealing 2012

Mar 16, 2012

SEC Form 3/A — Form 3/A

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2011-10-04

Reporting Person: Finizio Robert G (Director, Chief Executive Officer, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	22161586	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-qualified Stock Option	$0.1018	2019-01-01	Common Stock (1472910)		Direct
Common Stock Purchase Warrant	$0.2444	2021-03-09	Common Stock (204571)		Direct

Footnotes

F1: Option vests at the rate of 40,914 shares per month over the first three years from the date of issuance. Shares vested to date are 1,391,082. This option was assumed and re-issued pursuant to the Merger Agreement between the Company and VitaMedMD, LLC which closed on October 4, 2011.

F2: Warrant vests at the rate of 25,571 shares per calendar quarter.